Strategic use of new generation antidepressants for depression: SUN(^_^)D study protocol
Open Access
- 11 May 2011
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 12 (1) , 116
Abstract
After more than half a century of modern psychopharmacology, with billions of dollars spent on antidepressants annually world-wide, we lack good evidence to guide our everyday decisions in conducting antidepressant treatment of patients with major depression. First we did not know which antidepressant to use as first line treatment. Second we do not know which dosage we should be aiming at with that antidepressant. Because more than half of the patients with major depression starting treatment do not remit after adequate trial with the first agent, they will need a second line treatment. Dose escalation, augmentation and switching are the three often recommended second line strategies but we do not know which is better than the others. Moreover, we do not know when to start considering this second line treatment.Keywords
This publication has 53 references indexed in Scilit:
- Optimized Antidepressant Therapy and Pain Self-management in Primary Care Patients With Depression and Musculoskeletal PainJAMA, 2009
- Adequacy of continuation and maintenance treatments for major depression in JapanJournal of Psychopharmacology, 2008
- Selective Publication of Antidepressant Trials and Its Influence on Apparent EfficacyNew England Journal of Medicine, 2008
- Acceleration and Augmentation of Antidepressants With Lithium for Depressive DisordersThe Journal of Clinical Psychiatry, 2007
- Association Between Unreported Outcomes and Effect Size Estimates in Cochrane Meta-analysesJAMA, 2007
- Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorderThe World Journal of Biological Psychiatry, 2007
- Are we going to increase the use of antidepressants up to that of benzodiazepines?European Journal of Clinical Pharmacology, 2004
- Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) projectActa Psychiatrica Scandinavica, 2004
- The PHQ-9Journal of General Internal Medicine, 2001
- Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluationClinical Psychology Review, 1988